Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
806 Leser
Artikel bewerten:
(2)

Julius Meinl Living concludes the exchange offer for its existing bonds and successfully issues new 5-year bonds, enabling the group to focus on continued growth in the luxury hospitality market

DJ Julius Meinl Living concludes the exchange offer for its existing bonds and successfully issues new 5-year bonds, enabling the group to focus on continued growth in the luxury hospitality market

JML Finance (Luxembourg) sarl / Key word(s): Corporate Action/Issue of Debt 
Julius Meinl Living concludes the exchange offer for its existing bonds and successfully issues new 5-year bonds, 
enabling the group to focus on continued growth in the luxury hospitality market 
05-Jul-2024 / 18:00 CET/CEST 
=---------------------------------------------------------------------------------------------------------------------- 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO THE UNITED STATES OR TO ANY PERSON 
LOCATED OR RESIDENT IN THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS PRESS 
RELEASE. 
 
Julius Meinl Living concludes the exchange offer for its existing bonds pursuant to the exchange offer memorandum 
issued on 23 May 2024 and successfully issues new 5-year bonds, enabling the group to focus on continued growth in the 
luxury hospitality market 
 
On 23 May 2024, the Julius Meinl Living group announced an exchange offer on the existing EUR 30 million of 2019 / 2024 
bonds (ISIN: XS204298157) issued by JML Finance (Luxembourg) S.à r.l. (Ticker: JMLFIN) (the "Existing Notes") (the " 
Exchange Offer") and a new issue of 2024 / 2029 bonds (ISIN: XS2834253127) by JML Finance (Luxembourg) S.à r.l. (the " 
Issuer") under its EUR 300 million EMTN programme (the "New Notes"). 
 
Capitalised terms used in this announcement but not defined herein have the meanings given to them in the exchange 
offer memorandum dated 23 May 2024 (the "Exchange Offer Memorandum"). 
 
Further to the Exchange Offer, made on the terms and subject to the conditions set out in the Exchange Offer 
Memorandum, JML Finance (Luxembourg) S.à r.l. is pleased to confirm that the New Notes Coupon will be 7.0% p.a. paid 
semi-annually in cash; the New Notes Tenor will be 5 years; and the New Notes will be redeemed at maturity with a 
Redemption Amount at Maturity equal to 120% of the principal amount of each New Note. 
 
JML Finance (Luxembourg) S.à r.l. is additionally pleased to confirm that on 11th July 2024, it will be issuing and 
delivering a total of EUR 25.0 million of New Notes. Within this, the Acceptance Amount comprises of EUR 6.8 million, 
which will be accepted for exchange by JML Finance (Luxembourg) S.à r.l. pursuant to the Exchange Offer; the New Notes 
Issue Amount is an aggregate nominal amount of EUR 8.1 million of New Notes that will be issued at par; and a further 
EUR 10.1 million which will be held on behalf of the Issuer to facilitate future interest in the bond. 
 
SFI Markets acted as sole arranger and bookrunner of the transaction 
 
With the new issue having now reached first close, The Julius Meinl Living group confirms that the total issuance of 
the New Notes is capped at EUR 50 million. 
 
All of the Existing Notes issued by JML Finance (Luxembourg) S.à r.l. that have not been tendered pursuant to the 
Exchange Offer will mature in September 2024. Their redemption will be funded by the proceeds of the issuance of the 
New Notes and from other resources of the Julius Meinl Living group including cash from the group's previously 
announced EUR 12 million contribution of new equity by its shareholder. 
 
With the benefit of the ongoing issuance of the New Notes, of its continuing shareholder support and as well as the 
support of its banking partners, the Julius Meinl Living group continues to be in a position to press ahead with the 
development of its latest acquisition, the historic Hotel Ambasador in Bucharest and to progress its pipeline of other 
possible future acquisitions. 
 
The Hotel Ambasador will be the Julius Meinl Living group's second "The Julius" branded property and, when it opens in 
2027, will seek to replicate the success of the The Julius Prague. Having in 2023 achieved revenues of EUR 10.3 million 
and EBITDA of EUR 5.1 million, The Julius Prague is currently trading well ahead of prior year. 
 
Various attractive pipeline projects, located in major European political and economic capital cities, are currently at 
an advanced stage of review. 
 
Requests for information may be directed to: office@juliusmeinlliving.com. 
 
The information in this announcement is information that the Issuer is obliged to make public pursuant to the EU Market 
Abuse Regulation. 
=---------------------------------------------------------------------------------------------------------------------- 
Dissemination of a Financial Wire News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Language:   English 
Issuer:    JML Finance (Luxembourg) sarl 
       6 Rue Dicks 
       L-1417 Luxembourg 
       Luxembourg 
E-mail:    office@juliusmeinlliving.com 
Internet:   www.juliusmeinlliving.com 
ISIN:     XS2042981576 
EQS News ID: 1940815 
 
End of Announcement - EQS News Service 
=------------------------------------------------------------------------------------ 

1940815 05-Jul-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1940815&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

July 05, 2024 12:00 ET (16:00 GMT)

© 2024 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.